Document Detail

Next-generation sequencing in breast cancer: first take home messages.
MedLine Citation:
PMID:  23014189     Owner:  NLM     Status:  MEDLINE    
PURPOSE OF REVIEW: We are currently on the threshold of a revolution in breast cancer research, thanks to the emergence of novel technologies based on next-generation sequencing (NGS). In this review, we will describe the different sequencing technologies and platforms, and summarize the main findings from the latest sequencing articles in breast cancer.
RECENT FINDINGS: Firstly, the sequencing of a few hundreds of breast tumors has revealed new cancer genes. Although these were not frequently mutated, mutated genes from different patients could be grouped into the deregulation of similar pathways. Secondly, NGS allowed further exploration of intratumor heterogeneity and revealed that although subclonal mutations were present in all tumors, there was always a dominant clone, which comprised at least 50% of the tumor cells. Finally, tumor-specific DNA rearrangements could be detected in the patient's plasma, suggesting that NGS could be used to personalize the monitoring of the disease.
SUMMARY: The application of NGS to breast cancer has been associated with tremendous advances and promises for increasing the understanding of the disease. However, there still remain many unanswered questions, such as the role of structural changes of tumor genomes in cancer progression and treatment response/resistance.
Christine Desmedt; Thierry Voet; Christos Sotiriou; Peter J Campbell
Related Documents :
24021259 - Medicolegal considerations in breast health: the benefits of collaboration between ob/g...
24117859 - Neuroendocrine differentiation correlates with hormone receptor expression and decrease...
23851309 - Quantitative proteomic analysis of her2 normal and overexpressing mcf-7 breast cancer c...
23902919 - Evaluation of estrogenic, antiestrogenic and genotoxic activity of nemorosone, the majo...
25086679 - Dual-energy contrast-enhanced mammography.
23161709 - Molecular pathology of breast cancer: what a pathologist needs to know.
9815679 - Microsatellite instability is correlated with lymph node-positive breast cancer.
12521589 - Inflammation and anti-inflammatory therapy in chronic prostatitis.
1815419 - Memoirs of an amnesiac--two years with brain cancer, or the outer space of living with ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Current opinion in oncology     Volume:  24     ISSN:  1531-703X     ISO Abbreviation:  Curr Opin Oncol     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-10-19     Completed Date:  2013-03-28     Revised Date:  2014-02-24    
Medline Journal Info:
Nlm Unique ID:  9007265     Medline TA:  Curr Opin Oncol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  597-604     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Breast Neoplasms / genetics*,  metabolism,  pathology
Databases, Genetic
Gene Expression Profiling
Genetic Association Studies
Genetic Heterogeneity
High-Throughput Nucleotide Sequencing*
Individualized Medicine
Sequence Analysis, DNA
Sequence Analysis, RNA
Grant Support
088340//Wellcome Trust; 093867//Wellcome Trust

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Venous thromboembolism in the hematologic malignancies.
Next Document:  Analysis of protein expression in developmental toxicity induced by MeHg in zebrafish.